Question 1

Has Ashley Philip received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,193 in general payments to Ashley Philip across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Ashley Philip did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Ashley Philip come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$501
AbbVie	53	$452
Otsuka America Pharmaceutical, Inc.	8	$216
Neurocrine Biosciences, Inc.	6	$211
Collegium Pharmaceutical, Inc.	9	$187
Supernus Pharmaceuticals, Inc.	1	$113
Lundbeck LLC	6	$108
Vanda Pharmaceuticals Inc.	6	$95
Axsome Therapeutics, Inc.	4	$78
Bausch Health US, LLC	3	$71
Johnson & Johnson	2	$40
Takeda Pharmaceuticals U.S.A., Inc.	2	$38
Corium, LLC	2	$34
Tris Pharma Inc	1	$20
Alkermes, Inc.	1	$15
Vertical Pharmaceuticals, LLC	1	$15

Drug	Claims	Cost to plans & patients
Lorazepam	11	$60
Sertraline Hcl	19	$34

Ashley Philip

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Most prescribed under Part D

Other psychiatric/mental health in Southampton